UNITED THERAPEUTICS (UTHR) Short term Debt: 2017-2025
Historic Short term Debt for UNITED THERAPEUTICS (UTHR) over the last 3 years, with Mar 2025 value amounting to $200.0 million.
- UNITED THERAPEUTICS's Short term Debt fell 50.00% to $200.0 million in Q1 2025 from the same period last year, while for Mar 2025 it was $200.0 million, marking a year-over-year decrease of 50.00%. This contributed to the annual value of $300.0 million for FY2024, which is 25.00% down from last year.
- As of Q1 2025, UNITED THERAPEUTICS's Short term Debt stood at $200.0 million, which was down 33.33% from $300.0 million recorded in Q4 2024.
- Over the past 5 years, UNITED THERAPEUTICS's Short term Debt peaked at $400.0 million during Q4 2023, and registered a low of $200.0 million during Q1 2025.
- For the 3-year period, UNITED THERAPEUTICS's Short term Debt averaged around $342.9 million, with its median value being $400.0 million (2024).
- In the last 5 years, UNITED THERAPEUTICS's Short term Debt surged by 33.33% in 2024 and then crashed by 50.00% in 2025.
- Quarterly analysis of 3 years shows UNITED THERAPEUTICS's Short term Debt stood at $400.0 million in 2023, then fell by 25.00% to $300.0 million in 2024, then tumbled by 50.00% to $200.0 million in 2025.
- Its Short term Debt stands at $200.0 million for Q1 2025, versus $300.0 million for Q4 2024 and $400.0 million for Q3 2024.